* Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis, California 95616;
Global Research, Amersham Biosciences, Sunnyvale, California 94086; and
Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, California 95616
Received May 16, 2003; accepted September 22, 2003
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key Words: lung; heterogeneity; microdissection; RNA; preservation; real-time PCR; airways; parenchyma.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Standard techniques of RNA isolation require that the tissues be processed immediately following necropsy or quick-frozen in liquid nitrogen until RNA isolations can be performed. These requirements limit the number of animals that can be necropsied and processed in a single day. Frequently, when investigators are designing experiments they are faced with balancing the need to obtain RNA from lung subcompartments and collecting tissues for other types of analysis. This is particularly problematic for inhalation exposure studies, where many animals are exposed and need to be necropsied immediately. Time constraints and limited laboratory personnel dictate that gene expression is frequently measured in whole-lung tissues rather than site-specific lung subcompartments. Unfortunately, gene expression analysis performed in this manner can skew the data measured toward representing other subcompartments, diluting and masking focal site-specific areas of injury and the changes in gene expression associated with the injury.
Previously a technique was reported for the successful isolation of high-quality RNA from site-specific lung subcompartments (Royce et al., 1996). However, this approach required that microdissections and RNA isolations be performed immediately, with additional steps added to the RNA extraction protocol. Experiments designed to examine changes in gene expression in response to pulmonary toxicants had to utilize staggered treatment schedules because only small numbers of animals could be processed for RNA isolation in a single day.
The present study presents a simplified technique for preserving RNA in situ such that subcompartment microdissections can be conducted later by using RNAlater to inflate and store lungs. RNA synthesis and degradation are stopped immediately and subcompartment RNA is stabilized in situ, providing investigators with a precise snapshot in time of lung subcompartment gene expression. With appropriate storage, the lungs remain patent, and microdissections may be delayed after collecting lung tissues without RNA degradation. We found that with RNAlater the isolated lung subcompartment RNA is intact, of high quality, and may be used with real-time reverse transcription PCR (RT-PCR) for examining lung subcompartment gene expression.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1-nitronaphthalene treatment.
Additional male SpragueDawley rats were given a single intraperitoneal injection of 1-nitronaphthalene (1-NN, Aldrich, St Louis, MO) (100 mg/kg) dissolved in a corn-oil carrier (10 ml/kg). Two hours following injection the rats were euthanized, and their lungs were removed and processed as described above.
Lung subcompartment sampling procedure.
Site-specific lung subcompartment microdissections were performed 7 days following inflation of the lungs with RNAlater. The left lobe was separated from the remaining lobes, and the surface was blotted dry and glued to a glass coverslip with cyanoacrylate glue (Nexaband, Veterinary Product Laboratories, Phoenix, AZ). The coverslip-mounted lobe was placed in a petri dish, and a small piece of modeling clay was used to hold the coverslip in place while site-specific lung subcompartment microdissections were performed with a dissecting stereomicroscope. The site-specific subcompartments were isolated as illustrated in Fig. 1. The lateral edge of the left lobe, which does not contain airways, was cut away and used as the parenchymal compartment. Blunt dissection of the remaining parenchymal tissue was used to expose the airways.
|
Real-time RT-PCR.
All RT-PCR reagents were purchased from Applied Biosystems (Foster City, CA). RNA (200 ng) was reversed transcribed in a 25 µl reaction mixture containing 1X TaqMan RT Buffer, 5.5 mM MgCl2, 500 µl dNTPs, 2.5 µl random hexamers, 0.4 U/µl ribonuclease inhibitor, and 1.25 U/µl multiscribe reverse transcriptase. The reaction mixtures were incubated at 25°C for 10 min, 37°C for 60 min, and 95°C for 5 min. Primer and probe sequences were designed using Primer Express software (Applied Biosystems, Foster City, CA) and are listed in Table 1. The specificity of the primer probe sets was determined by agarose gel electrophoresis of PCR reaction products revealing a single band of expected size. Individual PCR reactions contained 1X TaqMan Mastermix, 1.25 µl of cDNA, 400-nM 5' and 3' primers, and 100 nM probe. PCR reactions were performed with an ABI 5700 sequence detection system using the following cycling protocol: 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C 1 for min. The results were calculated using the comparative Ct method as described previously (Applied Biosystems, 2001
). Briefly, the threshold cycle, Ct, is defined as the point at which the first significant increase in fluorescence is observed. The
Ct value is defined for each sample as the difference between the test gene and the reference gene, glyceraldehyde-3-phosphate dehydrogenase (GAPD), (Cttest gene - CtGAPD). The
Ct values of individual samples were then normalized to a calibrator sample for each gene by subtracting the
Ct(experimental sample) from the
Ct(calibrator sample). The reference calibrator sample used in these studies was whole-lung tissue RNA. Results are expressed as a fold difference in gene expression relative to whole-lung tissue RNA and were calculated using the formula: fold change = 2-
Ct.
|
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
Following 1-NN treatment, CYP2F4 was increased in the trachea four-fold and decreased two- to three-fold within the proximal and midlevel airways (Fig. 4A). CGRP was decreased five-fold in the trachea, increased in the airways two to four-fold, and was not detectable in the parenchyma (Fig. 4B
). The catalytic and regulatory subunits of
GCS were increased 310-fold in whole lung, trachea, and intrapulmonary lung subcompartments compared to the control (Fig. 4C and D
). HO1 expression increased in the whole lung, trachea and lung subcompartments 750-fold (Fig. 4E
). PLUNC was found mainly in the trachea and was increased approximately five-fold in 1-NN treated rat trachea (Fig. 4F
).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Real-time RT-PCR analysis of CYP2F4, CGRP, and the catalytic and regulatory subunits of GCS in normal lung demonstrated that gene expression can be either drastically different or highly similar among subcompartments in the lung. The increased levels of CYP2F4 and CGRP gene expression in the trachea and proximal airway segments are in agreement with observations made in the mouse (Shultz et al., 2001
). The site-specific differences in gene expression of
GCS catalytic and regulatory subunits by subcompartment has not been reported in the rat or any other species, but our results are in agreement with the similarities in
GCS enzyme activity previously reported in lung subcompartments of the mouse (West et al., 2000
).
The injury caused by the bioactivated pulmonary toxicant 1 NN has been described in Paige et al.(1997) and Sauer et al.(1997)
. The injury is airway site-specific (Paige et al., 2000
) and characterized by both ciliated and nonciliated Clara cell damage as well as an inflammatory cell infiltrate (Sauer et al., 1997
). The most severe injury occurs in the trachea, and the midlevel airways have the lowest threshold for injury (Paige et al., 2000
). The metabolism of 1 NN involves both P450-mediated bioactivation and glutathione metabolism (Halladay et al., 1999
). The present study revealed heterogeneous gene expression by lung subcompartment 2 h following 1-NN treatment whether the same gene was examined in multiple compartments or multiple genes were analyzed within the same compartment. CYP2F4 gene expression had the greatest increase in the trachea while it decreased or remained unchanged in the intrapulmonary compartments. The large amount of CYP2F4 present in the trachea following 1-NN treatment may partially account for the epithelial damage and denudation previously reported (Paige et al., 1997
), as mouse CYP2F2 can metabolize 1 NN in the mouse (Shultz et al., 2001
). Whether the same is true in the rat has yet to be determined.
GCS catalytic and regulatory subunits were increased following 1-NN treatment in whole lung, trachea, proximal midlevel and distal airways while the parenchyma had no change in the catalytic subunit and the regulatory subunit was decreased. Proliferation and increased staining of CGRP-positive neuroendocrine cells has been previously reported following acute lung injury (Stevens et al., 1997
). The present study similarly found that CGRP expression increased in the whole lung and intrapulmonary subcompartments and decreased five-fold in the trachea following 1-NN treatment. HO1 was increased in 1-NN treated rat whole lungs and different lung subcompartments, but not to the same degree, and has been described as being protective in a recent review (Otterbein et al., 2003
) via its ability to break down heme into CO, Fe++, and biliverdin. PLUNC is expressed mainly in the nose, trachea, and proximal intrapulmonary airways (Weston et al., 1999
). Following 1-NN treatment, the primary change in PLUNC expression was a five-fold increase in the trachea. While the biological function of PLUNC is unknown, it is believed that it plays a role in host defense due to its antibacterial properties (Bingle and Craven, 2002
). These real-time RT-PCR results emphasize the heterogeneity of gene expression in lung subcompartments subsequent to acute toxicant exposure and the importance of exercising caution when making conclusions regarding gene responses in difference lung microenvironments based on analysis of samples obtained from whole-lung tissue homogenates.
The greatest advantages of in situ RNA preservation combined with microdissection of lung subcompartments and RNA isolation are that: (1) RNA synthesis and degradation are immediately stopped following inflating the lungs with RNAlater, providing an immediate snapshot in time of gene expression in the lung; (2) high-quality RNA can be reproducibly isolated from identical microdissected airway segments from multiple animals; and (3) tissue microdissections and RNA isolation may be delayed without the loss of RNA integrity and quality. This technique allows investigators to measure gene expression from site-specific lung subcompartments with significant spatial and temporal precision, allowing the detection of focal changes in pulmonary gene expression that could be masked by measuring gene expression in the whole lung. Extensive detailed timecourse studies of gene expression may be performed with a high order of temporal precision using limited personnel. Previously, in order to study gene expression in such site-specific subcompartments, the lungs were first inflated with agarose at 37°C and incubated in cell culture media at 4°C, to allow the agarose to solidify, which delayed performing microdissections for 30 min (Royce et al., 1996). RNA from the microdissected samples needed to be isolated immediately following microdissections, and additional steps were added to the RNA isolation procedure to remove the contaminating agarose, which interfered with the RNA isolations. These requirements limited the number of animals being processed each day and are particularly problematic for inhalation exposure experiments where many animals must be necropsied at once and the number of laboratory personnel is limited. The present technique overcomes such problems and limitations. This RNA preservation and isolation technique is currently used to obtain RNA from the entire intrapulmonary airways tree for microarray analysis. To date, over 150 samples have been successfully hybridized. Some of the samples analyzed have been presented in manuscript form demonstrating differences in gene expression between the entire intrapulmonary airways tree and parenchyma (Shultz et al., 2003
). As a result of the small amounts of RNA isolated from lung subcompartments using the present technique, we have begun incorporating RNA amplification technologies (Wang et al., 2000
) to produce a sufficient amount of RNA for microarray analysis from lung subcompartments.
In summary, we have validated a technique that simplifies the isolation of intact, high-quality RNA from site-specific lung subcompartments that, when combined with RNA-based technologies, will significantly accelerate our understanding of the mechanisms of pulmonary injury and repair.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
NOTES |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Bingle, C. D., and Craven, C. J. (2002). PLUNC: A novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum. Mol. Genet. 11, 937943.
Cadieux, A., Springall, D. R., Mulderry, P. K., Rodrigo, J., Ghatei, M. A., Terenghi, G., Bloom, S. R., and Polak, J. M. (1986). Occurrence, distribution and ontogeny of CGRP immunoreactivity in the rat lower respiratory tract: effect of capsaicin treatment and surgical denervations. Neuroscience 19, 605627.[CrossRef][ISI][Medline]
Duan, X., Buckpitt, A. R., and Plopper, C. G. (1993). Variation in antioxidant enzyme activities in anatomic subcompartments within rat and rhesus monkey lung. Toxicol. Appl. Pharmacol. 123, 7382.[CrossRef][ISI][Medline]
Halladay, J. S., Sauer, J. M., and Sipes, I. G. (1999). Metabolism and disposition of [(14)C]1-nitronaphthalene in male Sprague-Dawley rats. Drug Metab. Dispos. 27, 14561465.
Lawson, G. W., Van Winkle, L. S., Toskala, E., Senior, R. M., Parks, W. C., and Plopper, C. G. (2002). Mouse strain modulates the role of the ciliated cell in acute tracheobronchial airway injury-distal airways. Am. J. Pathol. 160, 315327.
Otterbein, L. E., Soares, M. P., Yamashita, K., and Bach, F. H. (2003). Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24, 44955.[CrossRef][ISI][Medline]
Paige, R., Wong, V., and Plopper, C. (1997). Dose-related airway-selective epithelial toxicity of 1-nitronaphthalene in rats. Toxicol. Appl. Pharmacol. 147, 224233.[CrossRef][ISI][Medline]
Paige, R. C., Wong, V., and Plopper, C. G. (2000). Long-term exposure to ozone increases acute pulmonary centriacinar injury by 1-nitronaphthalene: II. Quantitative histopathology. J. Pharmacol. Exp. Ther. 295, 942950.
Plopper, C. G., Chu, F. P., Haselton, C. J., Peake, J., Wu, J., and Pinkerton, K. E. (1994). Dose-dependent tolerance to ozone. I. Tracheobronchial epithelial reorganization in rats after 20 months exposure. Am. J. Pathol. 144, 404420.[Abstract]
Plopper, C. G., Van Winkle, L. S., Fanucchi, M. V., Malburg, S. R., Nishio, S. J., Chang, A., and Buckpitt, A. R. (2001). Early events in naphthalene-induced acute Clara cell toxicity. II. Comparison of glutathione depletion and histopathology by airway location. Am. J. Respir. Cell Mol. Biol. 24, 272281.
Plopper, C. G., Weir, A., St.George, J. A., Tyler, N. K., Mariassy, A. T., Wilson, D., Nishio, S. J., Cranz, D. L., Heidsiek, J. G., and Hyde, D. (1989). Species differences in airway cell distribution and morphology. In Extrapolation of Dosimetric Relationships for Inhaled Particles and Gases (J. D. Crapo, Ed.), pp. 1934. Academic Press, San Diego, CA.
Royce, F. H., Van Winkle, L. S., Yin, J., and Plopper, C. G. (1996). Comparison of regional variability in lung-specific gene expression using a novel method for RNA isolation from lung subcompartments of rats and mice. Am. J. Pathol. 148, 17791786.[Abstract]
Sauer, J. M., Eversole, R. R., Lehmann, C. L., Johnson, D. E., and Beuving, L. J. (1997). An ultrastructural evaluation of acute 1-nitronaphthalene induced hepatic and pulmonary toxicity in the rat. Toxicol. Lett. 90, 1927.[CrossRef][ISI][Medline]
Shultz, M. A., Morin, D., Chang, A. M., and Buckpitt, A. (2001). Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung subcompartments. J. Pharmacol. Exp. Ther. 296, 510519.
Shultz, M. A., Zhang, L., Gu, Y. Z., Baker, G. L., Fannuchi, M. V., Padua, A. M., Gurske, W. A., Morin, D., Penn, S. G., Jovanovich, S. B., et al. (2003). Gene expression analysis in response to lung toxicants: I. Sequencing and microarray development. Am. J. Respir. Cell Mol. Biol.
Stevens, T. P., McBride, J. T., Peake, J. L., Pinkerton, K. E., and Stripp, B. R. (1997). Cell proliferation contributes to PNEC hyperplasia after acute airway injury. Am. J. Physiol. 272, L486L493.[ISI][Medline]
Van Winkle, L. S., Evans, M. J., Brown, C. D., Willits, N. H., Pinkerton, K. E., and Plopper, C. G. (2001). Prior exposure to aged and diluted sidestream cigarette smoke impairs bronchiolar injury and repair. Toxicol. Sci. 60, 152164.
Wang, E., Miller, L. D., Ohnmacht, G. A., Liu, E. T., and Marincola, F. M. (2000). High-fidelity mRNA amplification for gene profiling. Nat. Biotechnol. 18, 457459.[CrossRef][ISI][Medline]
West, J. A., Buckpitt, A. R., and Plopper, C. G. (2000). Elevated airway GSH resynthesis confers protection to Clara cells from naphthalene injury in mice made tolerant by repeated exposures. J. Pharmacol. Exp. Ther. 294, 516523.
Weston, W. M., LeClair, E. E., Trzyna, W., McHugh, K. M., Nugent, P., Lafferty, C. M., Ma, L., Tuan, R. S., and Greene, R. M. (1999). Differential display identification of plunc, a novel gene expressed in embryonic palate, nasal epithelium, and adult lung. J. Biol. Chem. 274, 1369813703.